• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/12/21 3:39:45 PM ET
    $VSPR
    Business Services
    Finance
    Get the next $VSPR alert in real time by email
    SC 13G 1 doc1.htm NONE Schedule 13G


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G
     
     
    Under the Securities Exchange Act of 1934
    (Amendment No. n/a )*
     
    Vesper Healthcare Acquisition Corp. 

    (Name of Issuer)
     
    Common Stock

    (Title of Class of Securities)
     
    92538T104

    (CUSIP Number)
     
    Calendar Year 2020

    (Date of Event Which Requires Filing of this Statement)
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
         x  Rule 13d-1(b)
     
         o  Rule 13d-1(c)
     
         o  Rule 13d-1(d)
     
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     


     
     

     
     
    CUSIP No.  92538T104      
     
          
    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     The Baupost Group, L.L.C.
    04-3402144
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

     (a)   o
     (b)   x
       
    3 SEC USE ONLY
      
      
       
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
      
     State of Delaware
        
    NUMBER OF SHARES BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER
      
     0
       
    6 SHARED VOTING POWER
      
     3,960,000
       
    7 SOLE DISPOSITIVE POWER
      
     0
       
    8 SHARED DISPOSITIVE POWER
      
     3,960,000
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     3,960,000
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
     o
       
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     8.61%
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     IA
     

    FOOTNOTES
      
     
     
     

     
     
    CUSIP No.  92538T104      
     
          
    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     Baupost Group GP, L.L.C.
    82-3254604
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

     (a)   o
     (b)   x
       
    3 SEC USE ONLY
      
      
       
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
      
     State of Delaware
        
    NUMBER OF SHARES BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER
      
     0
       
    6 SHARED VOTING POWER
      
     3,960,000
       
    7 SOLE DISPOSITIVE POWER
      
     0
       
    8 SHARED DISPOSITIVE POWER
      
     3,960,000
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     3,960,000
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
     o
       
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     8.61%
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     HC
     

    FOOTNOTES
      
     
     
     

     
     
    CUSIP No.  92538T104      
     
          
    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     Seth A. Klarman
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

     (a)   o
     (b)   x
       
    3 SEC USE ONLY
      
      
       
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
      
     The United States of America
        
    NUMBER OF SHARES BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER
      
     0
       
    6 SHARED VOTING POWER
      
     3,960,000
       
    7 SOLE DISPOSITIVE POWER
      
     0
       
    8 SHARED DISPOSITIVE POWER
      
     3,960,000
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     3,960,000
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
     o
       
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     8.61%
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     HC
     

    FOOTNOTES
      
     
     
     

     
     
    Item 1.

     
    (a)
    Name of Issuer
     
     
    Vesper Healthcare Acquisition Corp.

     
    (b)
    Address of Issuer’s Principal Executive Offices
     
     
    1819 West Avenue, Bay 2
    Miami Beach, FL 33139

    Item 2.

     
    (a)
    Name of Person Filing
     
     
    (1)
    The Baupost Group, L.L.C.
     
     
    (2)
    Baupost Group GP, L.L.C.
     
     
    (3)
    Seth A. Klarman

     
    (b)
    Address of Principal Business Office or, if none, Residence
     
     
    (1)
    The Baupost Group, L.L.C.
    10 St. James Avenue, Suite 1700
    Boston, Massachusetts 02116
     
     
    (2)
    Baupost Group GP, L.L.C.
    10 St. James Avenue, Suite 1700
    Boston, Massachusetts 02116
     
     
    (3)
    Seth A. Klarman
    10 St. James Avenue, Suite 1700
    Boston, Massachusetts 02116

     
    (c)
    Citizenship
     
     
    (1)
    The Baupost Group, L.L.C.: State of Delaware
     
     
    (2)
    Baupost Group GP, L.L.C.: State of Delaware
     
     
    (3)
    Seth A. Klarman: The United States of America

     
    (d)
    Title of Class of Securities
     
     
    Common Stock

     
    (e)
    CUSIP Number
     
     
    92538T104

     
    Item 3.
    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     
    (a)
    o
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

     
    (b)
    o
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     
    (c)
    o
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

     
    (d)
    o
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

     
    (e)
    x
    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

     
    (f)
    o
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

     
    (g)
    x
    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     
    (h)
    o
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     
    (i)
    o
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     
    (j)
    o
    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).

     
    (k)
    o
    A group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

     
     
     

     
     
    Item 4.
    Ownership.
     
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     
    (a)
    Amount beneficially owned:
     
     
    (1)
    The Baupost Group, L.L.C.: 3,960,000
     
     
    (2)
    Baupost Group GP, L.L.C.: 3,960,000
     
     
    (3)
    Seth A. Klarman: 3,960,000

     
    (b)
    Percent of class:
     
     
    (1)
    The Baupost Group, L.L.C.: 8.61%
     
     
    (2)
    Baupost Group GP, L.L.C.: 8.61%
     
     
    (3)
    Seth A. Klarman: 8.61%

     
    (c)
    Number of shares as to which the person has:

     
    (i)
    Sole power to vote or to direct the vote:
     
     
     
    (1)
    The Baupost Group, L.L.C.: 0
     
     
     
    (2)
    Baupost Group GP, L.L.C.: 0
     
     
     
    (3)
    Seth A. Klarman: 0

     
    (ii)
    Shared power to vote or to direct the vote:
     
     
     
    (1)
    The Baupost Group, L.L.C.: 3,960,000
     
     
     
    (2)
    Baupost Group GP, L.L.C.: 3,960,000
     
     
     
    (3)
    Seth A. Klarman: 3,960,000

     
    (iii)
    Sole power to dispose or to direct the disposition of:
     
     
     
    (1)
    The Baupost Group, L.L.C.: 0
     
     
     
    (2)
    Baupost Group GP, L.L.C.: 0
     
     
     
    (3)
    Seth A. Klarman: 0

     
    (iv)
    Shared power to dispose or to direct the disposition of:
     
     
     
    (1)
    The Baupost Group, L.L.C.: 3,960,000
     
     
     
    (2)
    Baupost Group GP, L.L.C.: 3,960,000
     
     
     
    (3)
    Seth A. Klarman: 3,960,000

    Item 5.
    Ownership of Five Percent or Less of a Class
     
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o .
     
     
     
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.
     
    Securities reported on this statement on Schedule 13G as being beneficially owned by The Baupost Group, L.L.C. were purchased on behalf of various private investment limited partnerships.
     
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
     
    See footnote.
     
    Item 8.
    Identification and Classification of Members of the Group
     
    N/A
     
    Item 9.
    Notice of Dissolution of Group
     
    N/A
     
     
     

     
     
     
    Item 10.
    Certification
      
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
     
     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
     
     The Baupost Group, L.L.C.
     
        
    Date: February 12, 2021
    By:
    /s/  Seth A. Klarman 
       Name: Seth A. Klarman 
       Title:  Chief Executive officer 
        
     
     
     
     Baupost Group GP, L.L.C.
     
        
    Date: February 12, 2021
    By:
    /s/  Seth A. Klarman 
       Name: Seth A. Klarman 
       Title:  Managing Member 
        
     
     
     
     Seth A. Klarman
     
        
    Date: February 12, 2021
    By:
    /s/  Seth A. Klarman 
       Name: Seth A. Klarman 
       
        
     
    Footnotes:
    Item 3, Item 4 and Item 7

    This statement on Schedule 13G is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. (“BG GP”) and Seth A. Klarman. Baupost is a registered investment adviser and acts as an investment adviser and general partner to various private investment limited partnerships. Securities reported on this statement on Schedule 13G as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost.

    Pursuant to Rule 13d-4, Seth A. Klarman and BG GP declare that the filing of this statement on Schedule 13G shall not be deemed an admission by either or both of them that they are, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this statement on Schedule 13G.

    Attention:
    Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
     
     


    Get the next $VSPR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VSPR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VSPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson initiated coverage on Vesper Healthcare Acquisition Corp. with a new price target

    DA Davidson initiated coverage of Vesper Healthcare Acquisition Corp. with a rating of Buy and set a new price target of $15.50

    4/13/21 6:59:11 AM ET
    $VSPR
    Business Services
    Finance

    The Benchmark Company initiated coverage on Vesper Healthcare Acquisition Corp. with a new price target

    The Benchmark Company initiated coverage of Vesper Healthcare Acquisition Corp. with a rating of Buy and set a new price target of $16.00

    3/18/21 7:41:55 AM ET
    $VSPR
    Business Services
    Finance

    Benchmark initiated coverage on Vesper Healthcare with a new price target

    Benchmark initiated coverage of Vesper Healthcare with a rating of Buy and set a new price target of $16.00

    3/18/21 6:57:43 AM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Linden and DW Healthcare Partners Complete HydraFacial's Public Offering via SPAC Merger

    CHICAGO and PARK CITY, Utah, May 5, 2021 /PRNewswire/ -- Linden Capital Partners ("Linden") and DW Healthcare Partners IV, LP ("DW Healthcare Partners"), both private equity firms focused exclusively on the healthcare sector, announced today the completion of the merger of Edge Systems, LLC ("HydraFacial"), a category-creating beauty health company, with Vesper Healthcare Acquisition Corp. (NASDAQ:VSPR) ("Vesper" or "Vesper Healthcare"). Vesper is a special purpose acquisition company ("SPAC") led by former Allergan CEO Brent Saunders. As a result of the transaction, the combined company, now known as The Beauty Health Company ("BeautyHealth" or the "Company"), is expected to trade on the Na

    5/5/21 7:30:00 AM ET
    $VSPR
    Business Services
    Finance

    HydraFacial Announces Record First Quarter Fiscal 2021 Preliminary Net Sales

    First Quarter 2021 Preliminary Financial Highlights: Q1 net sales of $47 million compared to $33 million in Q1 2020 and $35 million in Q1 2019 Q1 net sales in the Americas region of $31 million, or 66% of total net sales, compared to $24 million in Q1 2020 and $27 million in Q1 2019 Q1 net sales in the EMEA and APAC regions of $16 million, or 34% of total sales, compared to $9 million in Q1 2020 and $8 million in Q1 2019 The HydraFacial® Company ("HydraFacial," or the "Company"), an experiential category-creating beauty health company, today announced preliminary net sales for the quarter ended March 31, 2021. The Company has not yet completed the quarter-end review and expects to r

    4/21/21 6:45:00 AM ET
    $VSPR
    Business Services
    Finance

    HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales

    MIAMI BEACH, Fla. & LONG BEACH, Calif.--(BUSINESS WIRE)--The HydraFacial® Company (“HydraFacial,” or the “Company”), a category-creating beauty health company, today announced preliminary net sales for the fiscal year ended December 31, 2020. HydraFacial currently expects net sales for fiscal year 2020 to approximate $119 million. The Company’s previous expectation for net sales, provided on December 9, 2020, was approximately $115 million. The Company has not yet completed the year-end audit and expects to report full results for fiscal year 2020 at a future date. The previously announced business combination with Vesper Healthcare (NASDAQ: VSPR) remains on track to be completed

    2/22/21 6:45:00 AM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Woo Liyuan

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 8:00:17 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 4 filed by LCP Edge Holdco LLC

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 4:34:28 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 4 filed by SAUNDERS BRENT L

    4 - Beauty Health Co (0001818093) (Issuer)

    5/18/21 9:22:28 PM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    SEC Filings

    View All

    SEC Form 4 filed by Vesper Healthcare Acquisition Corp.

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 8:00:45 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 4 filed by Vesper Healthcare Acquisition Corp.

    4 - Beauty Health Co (0001818093) (Issuer)

    5/21/21 7:59:07 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form 8-K filed by Vesper Healthcare Acquisition Corp.

    8-K - Beauty Health Co (0001818093) (Filer)

    5/20/21 4:07:22 PM ET
    $VSPR
    Business Services
    Finance

    $VSPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Vesper Healthcare Acquisition Corp. (Amendment)

    SC 13D/A - Beauty Health Co (0001818093) (Subject)

    5/21/21 4:30:37 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form SC 13D filed by Vesper Healthcare Acquisition Corp.

    SC 13D - Beauty Health Co (0001818093) (Subject)

    5/14/21 4:23:32 PM ET
    $VSPR
    Business Services
    Finance

    SEC Form SC 13G filed

    SC 13G - Vesper Healthcare Acquisition Corp. (0001818093) (Subject)

    2/16/21 3:58:03 PM ET
    $VSPR
    Business Services
    Finance